BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7071912)

  • 1. Red blood cell concentrates stored at 4 degrees C for 34 days in CPDA-1, CPDA-2, or CPDA-3 anticoagulant-preservative, biochemically modified, and frozen and stored in the polyvinyl chloride plastic primary collection bag with 40% W/V glycerol at -80 degrees C.
    Valeri CR; Valeri DA; Gray A; Melaragno A; Dennis RC; Emerson CP
    Transfusion; 1982; 22(2):102-6. PubMed ID: 7071912
    [No Abstract]   [Full Text] [Related]  

  • 2. Viability and function of red blood cell concentrates stored at 4 degrees C for 35 days in CPDA-1, CPDA-2, or CPDA-3.
    Valeri CR; Valeri DA; Gray A; Melaragno A; Dennis RC; Emerson CP
    Transfusion; 1982; 22(3):210-6. PubMed ID: 7090034
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulation and function of human platelets isolated from units of CPDA-1, CPDA-2, and CPDA-3 anticoagulated blood and frozen with DMSO.
    Vecchione JJ; Melaragno AJ; Hollander A; Defina S; Emerson CP; Valeri CR
    Transfusion; 1982; 22(3):206-9. PubMed ID: 7090033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo viability of red blood cells stored in CPDA-2.
    Sohmer PR; Moore GL; Beutler E; Peck CC
    Transfusion; 1982; 22(6):479-84. PubMed ID: 7147326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
    Moroff G; Dende D
    Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
    Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
    Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the anticoagulant-preservative citrate-phosphate-adenine (CPDA-1) on blood services.
    McEvoy PM; Kahn RA; Miller WV
    Transfusion; 1982; 22(6):532-4. PubMed ID: 7147334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroxyacetone, pyruvate, and phosphate effects on 2,3 DPG and ATP in citrate-phosphate-dextrose-adenine blood preservation.
    Dawson RB; Fagan DS; Meyer DR
    Transfusion; 1984; 24(4):327-9. PubMed ID: 6464157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreserved red blood cells for pediatric transfusion. Frozen storage of small aliquots in polyvinyl chloride (PVC) plastic bags.
    Valeri CR; Valeri DA; Gray A; Melaragno AJ; Vecchione JJ; Dennis RC; Emerson CP
    Transfusion; 1981; 21(5):527-36. PubMed ID: 7292581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3-diphosphoglycerate.
    Kurup PA; Arun P; Gayathri NS; Dhanya CR; Indu AR
    Vox Sang; 2003 Nov; 85(4):253-61. PubMed ID: 14633250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of irradiation on red cells stored in CPDA-1 and CPD-ADSOL (AS-1).
    Jeter EK; Gadsden RH; Cate J
    Ann Clin Lab Sci; 1991; 21(3):177-86. PubMed ID: 1905899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some properties of blood stored in anticoagulant CPDA-1 solution. A brief summary.
    Moore GL; Peck CC; Sohmer PR; Zuck TF
    Transfusion; 1981; 21(2):135-7. PubMed ID: 7222197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Red cell preservation by freezing at -25 degrees C].
    Beaujean F; Le Forestier C; Duedari N
    Rev Fr Transfus Immunohematol; 1982 Sep; 25(4):427-38. PubMed ID: 7146751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biochemical effects of CPDA-2-drawn red blood cells of delayed refrigeration prior to component preparation.
    Moore GL; Ledford ME; Merydith A
    Transfusion; 1982; 22(6):485-7. PubMed ID: 7147327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated liquid-frozen blood banking system.
    Valeri CR; Sims KL; Bates JF; Reichman D; Lindberg JR; Wilson AC
    Vox Sang; 1983; 45(1):25-39. PubMed ID: 6880143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplification of the methods for adding and removing glycerol during freeze-preservation of human red blood cells with the high or low glycerol methods: biochemical modification prior to freezing.
    Valeri CR
    Transfusion; 1975; 15(3):195-218. PubMed ID: 1129830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adequate survival of red cells from units "undercollected" in citrate-phosphate-dextrose-adenine-one.
    Davey RJ; Lenes BL; Casper AJ; Demets DL
    Transfusion; 1984; 24(4):319-22. PubMed ID: 6464155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of red cell antigens and plasma coagulation factors stored in new formulation plastic blood containers.
    Snyder EL; Hezzey A; Weirich F; Mosher DF; Davisson W; Buchholz DH
    Transfusion; 1983; 23(1):49-53. PubMed ID: 6829059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of rejuvenation on the rheologic properties of stored erythrocytes].
    Barras JP; Moldovanyi A; Wagner S; Koerner K
    Vasa; 1994; 23(4):305-11. PubMed ID: 7817610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.